Search research articles
Contact Us
Filters
Showing results (381-390 of 455) with videos related to
Page
of 46
Sort By:
Lancet (London, England)
|
September 2, 2020
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
September 29, 2025
Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial
Erika Bonacina, Mireia Armengol-Alsina, Pablo Garcia-Manau, et al.
Journal of the American College of Cardiology
|
November 11, 2025
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial
Neal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, et al.
Journal of the American College of Cardiology
|
January 4, 2023
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Martin S Maron, Ahmad Masri, Lubna Choudhury, et al.
JACC. Clinical Electrophysiology
|
May 10, 2024
Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy
Francisco J Bermudez-Jimenez, Alexandros Protonotarios, Soledad García-Hernández, et al.
Plos One
|
August 4, 2017
Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy
Irene Mademont-Soler, Jesus Mates, Raquel Yotti, et al.
JACC. Heart Failure
|
November 30, 2023
Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design
Caroline J Coats, Martin S Maron, Theodore P Abraham, et al.
Journal of Cardiac Failure
|
March 17, 2024
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4
Ahmad Masri, Mark V Sherrid, Theodore P Abraham, et al.
European Heart Journal
|
March 20, 2026
Genetic counselling implementation in dilated cardiomyopathy
Job A J Verdonschot, Karin Y van Spaendonck-Zwarts, Debby M E I Hellebrekers, et al.
Nature Metabolism
|
March 15, 2022
Angiocrine polyamine production regulates adiposity
Erika Monelli, Pilar Villacampa, Amaia Zabala-Letona, et al.
Page
of 46
Search research articles
Search
Showing results (381-390 of 455) with videos related to
Sort By:
Page
of 46
Lancet (London, England)
|
September 2, 2020
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
September 29, 2025
Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial
Erika Bonacina, Mireia Armengol-Alsina, Pablo Garcia-Manau, et al.
Journal of the American College of Cardiology
|
November 11, 2025
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial
Neal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, et al.
Journal of the American College of Cardiology
|
January 4, 2023
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Martin S Maron, Ahmad Masri, Lubna Choudhury, et al.
JACC. Clinical Electrophysiology
|
May 10, 2024
Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy
Francisco J Bermudez-Jimenez, Alexandros Protonotarios, Soledad García-Hernández, et al.
Plos One
|
August 4, 2017
Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy
Irene Mademont-Soler, Jesus Mates, Raquel Yotti, et al.
JACC. Heart Failure
|
November 30, 2023
Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design
Caroline J Coats, Martin S Maron, Theodore P Abraham, et al.
Journal of Cardiac Failure
|
March 17, 2024
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4
Ahmad Masri, Mark V Sherrid, Theodore P Abraham, et al.
European Heart Journal
|
March 20, 2026
Genetic counselling implementation in dilated cardiomyopathy
Job A J Verdonschot, Karin Y van Spaendonck-Zwarts, Debby M E I Hellebrekers, et al.
Nature Metabolism
|
March 15, 2022
Angiocrine polyamine production regulates adiposity
Erika Monelli, Pilar Villacampa, Amaia Zabala-Letona, et al.
Page
of 46